OPR - Delayed Quote USD

SLDB Sep 2024 17.500 call (SLDB240920C00017500)

0.8000

0.0000

(0.00%)

At close: April 15 at 9:30 AM EDT

Key Events

Loading Chart for SLDB240920C00017500

9/21 12:03 PM

DELL

Previous Close 0.8000
Open 0.8000
Bid 0.1500
Ask 0.8000
Strike 17.50
Expire Date 2024-09-20
Day's Range 0.8000 - 0.8000
Contract Range --
Volume 1
Open Interest 7

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

Solid Biosciences (SLDB) Falls Despite FDA Rare Tag for DMD Drug

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Solid Biosciences Receives Rare Pediatric Disease Designation from the FDA for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback

How Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A Comeback

Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium

Solid Biosciences to Participate at Cantor’s Virtual Muscular Dystrophy Symposium

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

Solid Biosciences Provides Fourth Quarter and Full-Year 2023 Business Update and Financial Results

Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD

Solid Biosciences Announces Licensing Agreement with Armatus Bio for the Use of AAV-SLB101, a Proprietary, Muscle-Targeted Capsid, in the Development of an RNAi Therapy to treat FSHD

Solid Biosciences to Participate at Upcoming Investor Conferences

Solid Biosciences to Participate at Upcoming Investor Conferences

14 Stocks With Heavy Insider Buying In 2024

14 Stocks With Heavy Insider Buying In 2024

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update

Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up

Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003

Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003